Anna Lawrence

Anna graduated with a B.E in Genetic Engineering from SRM university in August 2024. Her Bachelor’s thesis was at the Brigham and Women’s hospital (Harvard) under the guidance of Drs. Vinay Mahajan and Shiladitya Sengupta. She developed a unique and scalable chemistry for generating nanobody drug conjugates that are poised to treat fibrotic disorders like SSc.She joined the Müschen lab in August 2025 where she will work with Dr. Cosgun to investigate Wnt/Beta-catenin signaling in B cell malignancies with a therapeutic approach.